EMEA launches EudraPharm drugs database
The European Medicines Agency (EMEA) has launched a new public drugs database, called EudraPharm. The facility is available on-line at www.eudrapharm.eu.
EMEA Executive Director Thomas Lonngren said: "once fully developed, this database will be the reference point for independent information about all the medicines available to Europeans, no matter whether these medicines have been authorized at European Union or national level."
In the first stage, drugs that have been authorized by the European Commission following assessment by the EMEA are included on the web site. These are authorized for the 25 European Union member states as well as Iceland, Liechtenstein and Norway. The database is currently only available in English, however, the other EU official languages are being added, together with improved search functions, according to the EMEA.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze